Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 11|pp. 10074–10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Back to articleFigure 5(5 of 6)
100%
Figure 5
Figure 5.Radar map of TMB versus MSI scores in pan-cancer. (A) Radar chart of TMB score; (B) Radar chart of MSI score.
Figure 5 — Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3 | Aging